{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:30:22Z","timestamp":1792521022717,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.apsb.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:35:32Z","timestamp":1715618132000},"page":"3513-3527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription"],"prefix":"10.1016","volume":"14","author":[{"given":"Xue","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiqin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.05.005_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.apsb.2023.11.011","article-title":"Mechanism of action of the bile acid receptor TGR5 in obesity","volume":"14","author":"Lun","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.05.005_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/mend.16.5.0828","article-title":"Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors","volume":"16","author":"Moore","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2024.05.005_bib6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.05.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.06.029","article-title":"The intestinal microbiome restricts alphavirus infection and dissemination through a bile acid-type I IFN signaling axis","volume":"182","author":"Winkler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.05.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2021.109097","article-title":"Bile acids LCA and CDCA inhibited porcine deltacoronavirus replication in\u00a0vitro","volume":"257","author":"Kong","year":"2021","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.apsb.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/hep.510290617","article-title":"Bile acids modulate the interferon signalling pathway","volume":"29","author":"Podevin","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2024.05.005_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2024.05.005_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41422-018-0136-1","article-title":"Virus-induced accumulation of intracellular bile acids activates the TGR5\u2013\u03b2-arrestin\u2013SRC axis to enable innate antiviral immunity","volume":"29","author":"Hu","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2024.05.005_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2007.09.015","article-title":"Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR","volume":"48","author":"Scholtes","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.05.005_bib15","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.apsb.2023.01.023","article-title":"Commentary: can FXR serve as a potential target for COVID-19 prevention?","volume":"13","author":"Pang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.05.005_bib16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3389\/fimmu.2018.02289","article-title":"metabolite-sensing G protein coupled receptor TGR5 protects host from viral infection through amplifying type I interferon responses","volume":"9","author":"Xiong","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2024.05.005_bib17","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/JVI.06742-11","article-title":"Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in\u00a0vivo","volume":"86","author":"Reese","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2024.05.005_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.31712","article-title":"Dual agonist of farnesoid X receptor and Takeda G protein-coupled receptor 5 inhibits hepatitis B virus infection in\u00a0vitro and in\u00a0vivo","volume":"74","author":"Ito","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.05.005_bib19","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.apsb.2021.12.011","article-title":"Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.05.005_bib20","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1021\/acs.jmedchem.9b00770","article-title":"7-Methylation of chenodeoxycholic acid derivatives yields a substantial increase in TGR5 receptor potency","volume":"62","author":"Nakhi","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.05.005_bib21","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4161\/cc.21029","article-title":"Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation","volume":"11","author":"Casaburi","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2024.05.005_bib22","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.05.005_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2024.05.005_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13949","article-title":"Transcriptional regulation of autophagy by an FXR\u2013CREB axis","volume":"516","author":"Seok","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.05.005_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.1138104","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator 1alpha (PGC-1\u03b1) regulates triglyceride metabolism by activation of the nuclear receptor FXR","volume":"18","author":"Zhang","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.apsb.2024.05.005_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1023668705040","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume":"8","author":"Chawla-Sarkar","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.apsb.2024.05.005_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bbrc.2013.11.007","article-title":"LC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation","volume":"441","author":"Liu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2024.05.005_bib28","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.bmc.2014.04.014","article-title":"Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor","volume":"22","author":"Yu","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2024.05.005_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.05.005_bib30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1126\/science.1072891","article-title":"A natural product that lowers cholesterol as an antagonist ligand for FXR","volume":"296","author":"Urizar","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.05.005_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2016.10.017","article-title":"Differential modulation of FXR activity by chlorophacinone and ivermectin analogs","volume":"313","author":"Hsu","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2024.05.005_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.368","article-title":"Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in\u00a0vitro cell models","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol Res Perspect"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T23:12:04Z","timestamp":1723072324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2211383524001837"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.05.005","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}